Cite
HARVARD Citation
Koshizaka, M. et al. (2019). Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study). Diabetes, obesity & metabolism. 21 (8), pp. 1990-1995. [Online].